Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Equity (2016 - 2025)

OptimizeRx's Return on Equity history spans 15 years, with the latest figure at 0.04% for Q3 2025.

  • For Q3 2025, Return on Equity rose 31.0% year-over-year to 0.04%; the TTM value through Sep 2025 reached 0.04%, up 31.0%, while the annual FY2024 figure was 0.13%, 1.0% up from the prior year.
  • Return on Equity for Q3 2025 was 0.04% at OptimizeRx, up from 0.04% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.04% in Q3 2025 and bottomed at 0.27% in Q3 2024.
  • The 5-year median for Return on Equity is 0.09% (2022), against an average of 0.09%.
  • The largest annual shift saw Return on Equity dropped -15bps in 2024 before it soared 31bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then plummeted by -3155bps to 0.09% in 2022, then crashed by -131bps to 0.21% in 2023, then soared by 36bps to 0.13% in 2024, then soared by 130bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Return on Equity are 0.04% (Q3 2025), 0.04% (Q2 2025), and 0.09% (Q1 2025).